PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

NCT00523107 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Fatigue

Interventions

DRUG: PG2
DRUG: Placebo

Sponsor

PhytoHealth Corporation